Feng Shao
邵峰
Feng Shao is a Chinese scientist and biotech entrepreneur who did postdoctoral work at Harvard Medical School in 2003–2004 after completing his PhD , and later co-founded Inming Biotech (炎明生物, also known as Pyrotech Therapeutics) with Deng Tianjing . The company has been covered in 峰瑞资本 (FreeS Capital) funding news as part of its portfolio.
elsewhere's corpus does not contain deeper biographical coverage of Feng Shao himself — the retrieved material notes his scientific training and this single venture, but does not profile his broader career, current role, or other activities.
AI-generated — may contain errors, please verify.
Coverage
New Listings and New Funding: 10 Developments in the Height of Summer | FreeS Family Funding News Vol.19
Looking forward to working alongside more outstanding founders.
FreeS Family Funding News · July | PatPat, Yanming Biotech, Qbit, and Innostar Secure Financing
We've also released three short videos this issue — follow us to check them out.
Li Feng in Conversation with Academician Shao Feng: New Trends in Drug Discovery
How Can Basic Research Better Connect with Industry in Biomedicine, a Field Where "the Barrier to Entry Is Low, but the Courtyard Runs Deep"?
Li Feng in Conversation with Academician Shao Feng: First In Class in China | Last 2 Days to Register
How can basic biomedical research better connect with industry?
Beyond the "Narrow Door": A Real-World Portrait of Early-Stage Frontier Biotech Entrepreneurship in China | FreeS Fund 2020 Biotech Summit Registration Now Open
Will Today’s US Biotech Become China’s Tomorrow?
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
